ABSTRACT
In the late 1950s it became possible to rescue human beings from the hazardous consequences of lethal irradiation by infusion of bone marrow cells.1,2
In over 4 decades since then, with the advances of technology and knowledge developed in this period, haematopoietic stem cell transplantation (SCT) has become common practice and a potential curative option for haematological malignancies including lymphomas, solid tumours and other non-malignant disorders.3
